|
1
|
Mebazaa A, Yilmaz MB, Levy P, Ponikowski
P, Peacock WF, Laribi S, Ristic AD, Lambrinou E, Masip J, Riley JP,
et al: Recommendations on pre-hospital & early hospital
management of acute heart failure: A consensus paper from the Heart
Failure Association of the European Society of Cardiology, the
European Society of Emergency Medicine and the Society of Academic
Emergency Medicine. Eur J Heart Fail. 17:544–558. 2015.PubMed/NCBI View
Article : Google Scholar
|
|
2
|
Matsue Y, Damman K, Voors AA, Kagiyama N,
Yamaguchi T, Kuroda S, Okumura T, Kida K, Mizuno A, Oishi S, et al:
Time-to-Furosemide treatment and mortality in patients hospitalized
with acute heart failure. J Am Coll Cardiol. 69:3042–3051.
2017.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Chioncel O, Mebazaa A, Harjola VP, Coats
AJ, Piepoli MF, Crespo-Leiro MG, Laroche C, Seferovic PM, Anker SD,
Ferrari R, et al: Clinical phenotypes and outcome of patients
hospitalized for acute heart failure: The ESC Heart Failure
Long-term registry. Eur J Heart Fail. 19:1242–1254. 2017.PubMed/NCBI View
Article : Google Scholar
|
|
4
|
Maaten JMT, Valente MAE, Damman K, Hillege
HL, Navis G and Voors AA: Diuretic response in acute heart
failure[mdash]pathophysiology, evaluation, and therapy. Nat Rev
Cardiol. 12(184)2015.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Xu H, Wang B, Meng Q, Li J, Sun W, Xin L
and Chen L: Effectiveness and safety of recombinant human brain
natriuretic peptide in the treatment of acute myocardial infarction
in elderly in combination with cardiac failure. Pak J Med Sci.
33:540–544. 2017.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Yu L, Shi X, Han C, Rao C and Wang J: A
rapid reporter assay for recombinant human brain natriuretic
peptide (rhBNP) by GloSensor technology. J Pharm Anal. 8:297–301.
2018.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Zhang S and Wang Z: Effect of recombinant
human brain natriuretic peptide (rhBNP) versus nitroglycerin in
patients with heart failure: A systematic review and meta-analysis.
Medicine (Baltimore). 95(e4757)2016.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Su Z, Wei G, Wei L, Liu J and Li X:
Effects of rhBNP on myocardial fibrosis after myocardial infarction
in rats. Int J Clin Exp Pathol. 8:6407–6415. 2015.PubMed/NCBI
|
|
9
|
Cruz JE, Thomas Z, Lee D, Moskowitz DM and
Nemeth J: Therapeutic interchange of clevidipine for sodium
nitroprusside in cardiac surgery. P T. 41:635–639. 2016.PubMed/NCBI
|
|
10
|
Olesen ND, Fischer M and Secher NH: Sodium
nitroprusside dilates cerebral vessels and enhances internal
carotid artery flow in young men. J Physiol. 596:3967–3976.
2018.PubMed/NCBI View
Article : Google Scholar
|
|
11
|
Fisher JD: New York Heart Association
classification. Arch Intern Med. 129(836)1972.PubMed/NCBI
|
|
12
|
Chiem AT, Chan CH, Ander DS, Kobylivker AN
and Manson WC: Comparison of expert and novice sonographers'
performance in focused lung ultrasonography in dyspnea (FLUID) to
diagnose patients with acute heart failure syndrome. Acad Emerg
Med. 22:564–573. 2015.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Bredy C, Ministeri M, Kempny A,
Alonso-Gonzalez R, Swan L, Uebing A, Diller GP, Gatzoulis MA and
Dimopoulos K: New York Heart Association (NYHA) classification in
adults with congenital heart disease: Relation to objective
measures of exercise and outcome. Eur Heart J Qual Care Clin
Outcomes. 4:51–58. 2018.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Kaski JC: Cardiac Syndrome X and
Microvascular Angina, 1999.
|
|
15
|
Ziaeian B and Fonarow GC: Epidemiology and
aetiology of heart failure. Nat Rev Cardiol. 13:368–378.
2016.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Sinnenberg L and Givertz MM: Acute heart
failure. Trends Cardiovasc Med. 30:104–112. 2019.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Harjola VP, Mullens W, Banaszewski M,
Bauersachs J, Brunner-La Rocca HP, Chioncel O, Collins SP, Doehner
W, Filippatos GS, Flammer AJ, et al: Organ dysfunction, injury and
failure in acute heart failure: From pathophysiology to diagnosis
and management. A review on behalf of the Acute Heart Failure
Committee of the Heart Failure Association (HFA) of the European
Society of Cardiology (ESC). Eur J Heart Fail. 19:821–836.
2017.PubMed/NCBI View
Article : Google Scholar
|
|
18
|
Kastl SP, Krychtiuk KA, Lenz M,
Distelmaier K, Goliasch G, Huber K, Wojta J, Heinz G and Speidl WS:
Intestinal fatty acid binding protein is associated with mortality
in patients with acute heart failure or cardiogenic shock. Shock.
51:410–415. 2019.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Harjola VP, Parissis J, Brunner-La Rocca
HP, Čelutkienė J, Chioncel O, Collins SP, De Backer D, Filippatos
GS, Gayat E, Hill L, et al: Comprehensive in-hospital monitoring in
acute heart failure: Applications for clinical practice and future
directions for research. A statement from the Acute Heart Failure
Committee of the Heart Failure Association (HFA) of the European
Society of Cardiology (ESC). Eur J Heart Fail. 20:1081–1099.
2018.PubMed/NCBI View Article : Google Scholar
|
|
20
|
He XM, Chen L, Luo JB, Feng XX, Zhang YB,
Chen QJ, Ji XL and Wang TS: Effects of rhBNP after PCI on
non-invasive hemodynamic in acute myocardial infarction patients
with left heart failure. Asian Pac J Trop Med. 9:791–795.
2016.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Hua P, Liu J, Tao J, Lin X, Zou R, Zhang D
and Yang S: Safety and efficacy of the perioperative administration
of recombinant human brain natriuretic peptide (rhBNP): A
systematic review and meta-analysis. Ther Clin Risk Manag.
14:313–321. 2018.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Farooq A, Whitehead D and Azzawi M:
Attenuation of endothelial-dependent vasodilator responses, induced
by dye-encapsulated silica nanoparticles, in aortic vessels.
Nanomedicine (Lond). 9:413–425. 2014.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Fida TT, Voordouw J, Ataeian M, Kleiner M,
Okpala G, Mand J and Voordouw G: Synergy of sodium nitroprusside
and nitrate in inhibiting the activity of sulfate reducing bacteria
in Oil-containing bioreactors. Front Microbiol.
9(981)2018.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Wei X, Yan T, Dai H and Wei Z: Clinical
efficacy of rhBNP in treating AHF and its effect on hemodynamics
and inflammatory factors. Chongqing Med. 27:2017.(In Chinese).
|
|
25
|
Guiha NH, Cohn JN, Mikulic E, Franciosa JA
and Limas CJ: Treatment of refractory heart failure with infusion
of nitroprusside. N Engl J Med. 291:587–592. 1974.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Mullens W, Abrahams Z, Francis GS, Skouri
HN, Starling RC, Young JB, Taylor DO and Tang WH: Sodium
nitroprusside for advanced low-output heart failure. J Am Coll
Cardiol. 52:200–207. 2008.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Strassheim D, Dempsey EC, Gerasimovskaya
E, Stenmark K and Karoor V: Role of inflammatory cell subtypes in
heart failure. J Immunol Res. 2019:1–9. 2019.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Apple FS, Steffen LM, Pearce LA, Murakami
MM and Luepker RV: Increased cardiac troponin I as measured by a
high-sensitivity assay is associated with high odds of
cardiovascular death: The Minnesota Heart Survey. Clin Chem.
58:930–935. 2012.PubMed/NCBI View Article : Google Scholar
|
